Related Experiment Videos
Fluoxetine prophylaxis of migraine
C Adly1, J Straumanis, A Chesson
1Department of Psychiatry, Louisiana State University School of Medicine, Shreveport.
Headache
|February 1, 1992
Summary
Fluoxetine effectively reduced severe migraine headaches in a clinical trial. This serotonin-based medication offers a safe prophylactic option for patients unresponsive to other treatments.
Area of Science:
- Neurology
- Pharmacology
Background:
- Severe migraine patients often lack effective treatments or experience intolerable side effects.
- Serotonin dysregulation is implicated in the underlying mechanisms of migraine.
Purpose of the Study:
- To investigate the prophylactic efficacy of fluoxetine, a serotonergic drug, in patients with severe migraine.
Main Methods:
- A double-blind, placebo-controlled study was conducted over 8 weeks.
- Participants were randomly assigned to receive either fluoxetine or a placebo.
- Migraine headache and depression scores were recorded throughout the study.
Main Results:
- Fluoxetine significantly reduced migraine headache scores from weeks 3-4 onwards.
- No significant changes in headache scores were observed in the placebo group.
- No significant differences in depression scores were found between the fluoxetine and placebo groups.
Conclusions:
- Fluoxetine demonstrates potential as a safe and effective prophylactic treatment for severe migraine.
- Further large-scale, long-term studies are warranted to confirm these findings.